Effects of modafinil on cognitive functions in first episode psychosis

被引:46
作者
Scoriels, Linda [1 ]
Barnett, Jennifer H.
Soma, Praveen K.
Sahakian, Barbara J. [1 ]
Jones, Peter B.
机构
[1] Univ Cambridge, Dept Psychiat, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 0SZ, England
基金
英国惠康基金;
关键词
Modafinil; Schizophrenia; Psychosis; Cognition; Working memory; Strategy use; Inhibition control; RESPONSE-INHIBITION; IMPROVES COGNITION; EXECUTIVE FUNCTION; DOUBLE-BLIND; MEMORY; PERFORMANCE; SLEEP; SCHIZOPHRENIA; AMPHETAMINE; IMPULSIVITY;
D O I
10.1007/s00213-011-2472-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Cognitive impairments are important determinants of functional outcome in psychosis, which are inadequately treated by antipsychotic medication. Modafinil is a wake-promoting drug that has been shown to improve attention, memory and executive function in the healthy population and in patients with schizophrenia. Objectives We aimed to establish modafinil's role in the adjunctive treatment of cognitive impairments in the first episode of psychosis, a time when symptoms may be more malleable than at chronic stages of the disease. Methods Forty patients with a first episode of psychosis participated in a randomised, double-blind, placebo-controlled crossover design study assessing the effects of a single dose of 200 mg modafinil on measures of executive functioning, memory, learning, impulsivity and attention. Results Modafinil improved verbal working memory (d = 0.24, p = 0.04), spatial working memory errors (d = 0.30, p = 0.0004) and strategy use (d = 0.23, p = 0.03). It also reduced discrimination errors in a task testing impulsivity. Modafinil showed no effect on impulsivity measures, sustained attention, attentional set-shifting, learning or fluency. Conclusions Modafinil selectively enhances working memory in first episode psychosis patients, which could have downstream effects on patients' social and occupational functioning.
引用
收藏
页码:249 / 258
页数:10
相关论文
共 54 条
[1]   Diagnostic stability over one year in first-episode psychosis [J].
Addington, Jean ;
Chaves, Ana ;
Addington, Donald .
SCHIZOPHRENIA RESEARCH, 2006, 86 (1-3) :71-75
[2]   Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans [J].
Aron, AR ;
Fletcher, PC ;
Bullmore, ET ;
Sahakian, BJ ;
Robbins, TW .
NATURE NEUROSCIENCE, 2003, 6 (02) :115-116
[3]   The mental wealth of nations [J].
Beddington, John ;
Cooper, Cary L. ;
Field, John ;
Goswami, Usha ;
Huppert, Felicia A. ;
Jenkins, Rachel ;
Jones, Hannah S. ;
Kirkwood, Tom B. L. ;
Sahakian, Barbara J. ;
Thomas, Sandy M. .
NATURE, 2008, 455 (7216) :1057-1060
[4]   Improvement of learning processes following chronic systemic administration of modafinil in mice [J].
Béracochéa, D ;
Celerier, A ;
Borde, N ;
Valleau, M ;
Peres, M ;
Pierard, C .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (03) :723-728
[5]   Reflection impulsivity in current and former substance users [J].
Clark, Luke ;
Robbins, Trevor W. ;
Ersche, Karen D. ;
Sahakian, Barbara J. .
BIOLOGICAL PSYCHIATRY, 2006, 60 (05) :515-522
[6]   A neural circuit basis for spatial working memory [J].
Constantinidis, C ;
Wang, XJ .
NEUROSCIENTIST, 2004, 10 (06) :553-565
[7]   Comparison of Steady-State Plasma Concentrations of Armodafinil and Modafinil Late in the Day Following Morning Administration Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies in Healthy Male Subjects [J].
Darwish, Mona ;
Kirby, Mary ;
Hellriegel, Edward T. .
CLINICAL DRUG INVESTIGATION, 2009, 29 (09) :601-612
[8]  
Doughty O J, 2009, Cogn Neuropsychiatry, V14, P473, DOI 10.1080/13546800903073291
[9]   Response inhibition and impulsivity in schizophrenia [J].
Enticott, Peter G. ;
Ogloff, James R. P. ;
Bradshaw, John L. .
PSYCHIATRY RESEARCH, 2008, 157 (1-3) :251-254
[10]   The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat:: Prevention by local GABAA receptor blockade [J].
Ferraro, L ;
Antonelli, T ;
Tanganelli, S ;
O'Connor, WT ;
de la Mora, MP ;
Mendez-Franco, J ;
Rambert, FA ;
Fuxe, K .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (04) :346-356